News
ONVO
--
0.00%
--
Is Organovo Holdings Inc (ONVO) A Good Stock To Buy?
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors are starting to get cautious towards the current bull run since March, 2020 an...
Insider Monkey · 2d ago
Asensus Surgical to join Russell Microcap Index, while Sorrento Therapeutics to see deletion
At the conclusion of the 2021 Russell indexes annual reconstitution, following notable healthcare stocks will join the Russell Microcap Index, effective June 28 after the U.S. market opens.Asensus Surgical (ASXC), Organovo
Seekingalpha · 3d ago
Organovo Holdings Granted European Patent Titled 'AUTOMATED DEVICES, SYSTEMS, AND METHODS FOR THE FABRICATION OF TISSUE'
https://register.epo.org/application?number=EP14832338
Benzinga · 06/01 19:13
44 Biggest Movers From Friday
Gainers
Benzinga · 06/01 09:21
ONVO, YEXT, CTRM and SLCA among midday movers
Gainers: SemiLEDs (LEDS) +49%.Vertex Energy (VTNR) +45%.Organovo (ONVO) +28%.eMagin (EMAN) +24%.Mannatech (MTEX) +21%.Welbilt (WBT) +21%.Yext (YEXT) +19%.MoSys (MOSY) +16%.Embotelladora Andina (AKO-B) +13%.Iterum Therapeutics (ITRM) +17%.Losers: 1847 Goede...
Seekingalpha · 05/28 16:39
12 Health Care Stocks Moving In Friday's Intraday Session
 
Benzinga · 05/28 16:32
Organovo up 36% on bullish assessment of 3D human tissue biotech
Organovo Holdings (ONVO) has rocketed 36% to $9.80 in afternoon trading after Seeking Alpha contributor Gunner Laine Hardy offered a bullish assessment behind the 3D human tissue biotech.While Hardy cautions the stock
Seekingalpha · 05/28 16:11
Organovo, Iterum Therapeutics leads healthcare gainers; Provention Bio, Eton Pharmaceuticals among major losers
Gainers: Organovo (ONVO) +24%, Iterum Therapeutics (ITRM) +16%, Adagene (ADAG) +14%, Freeline Therapeutics (FRLN) +12%, 180 Life Sciences (ATNF) +12%.Losers: Provention Bio (PRVB) -22%, Eton Pharmaceuticals (ETON) -13%, Lannett (LCI) -12%, Regional Health ...
Seekingalpha · 05/28 15:03
Mid-Morning Market Update: Markets Open Higher; Big Lots Posts Upbeat Q1 Profit
Following the market opening Friday, the Dow traded up 0.24% to 34,547.73 while the NASDAQ rose 0.44% to 13,796.49. The S&P also rose, gaining 0.21% to 4,209.59.
Benzinga · 05/28 14:21
Organovo Shares Up 26%; Recent Seeking Alpha Article 'Organovo: New Strategy Targeting Internal Pipeline Development With Customized 3D Human Tissues Offers Upside'
https://seekingalpha.com/article/4431909-organovo-new-strategy-targetting-internal-pipeline-development-offers-upside
Benzinga · 05/28 14:12
At 17% CAGR, Global 3D Printed Medical Devices Market Size & Share Will Reach USD 4 Billion By 2026: Facts & Factors
Facts and Factors have published a new research report titled "3D Printed Medical Devices Market By Component (Software & Services, 3D Printers & 3D Bioprinters, Material, & Others), By Type (Surgical Guides, Dental Guides, Craniomaxillofacial Guides, O...
GlobeNewswire · 05/28 12:39
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Benzinga · 05/21 12:13
Cathie Wood's Ark Loads Up Further On Tesla And Cuts Apple Stake
Cathie Wood-led Ark Investment Management on Tuesday snapped up $27.2 million worth of shares in Tesla Inc (NASDAQ: TSLA) after a two-week gap during which shares of the electric vehicle company have retreated about 15%.
Benzinga · 05/19 04:32
Cathie Wood Cuts Apple Stake Almost Entirely — And Buys More Coinbase
Cathie Wood-led Ark Investment Management on Monday shed nearly all of its stake in Apple Inc (NASDAQ: AAPL) and continued to snap up shares of Coinbase Global Inc (NASDAQ: COIN).
Benzinga · 05/18 05:20
Cathie Wood Buys $26M Disney Shares And Sells $13M In Netflix: What You Need To Know
Cathie Wood-led Ark Investment Management on Friday bought 150,556 shares, worth about $26.15 million, in Walt Disney Co (NYSE: DIS), marking its debut in the media and entertainment company as analysts pointed to benefits from the reopening of theme parks...
Benzinga · 05/17 03:33
3D Printing for Medical Sector Market to Witness Steady Growth Rate During 2020 to 2027 and will Surpass US$ Billion/Million Values by 2027-End
May 12, 2021 (Market Insight Reports) -- 3D Printing for Medical Sector Market to Surpass US$ 1447.6 Mn Threshold by 2027 – Coherent Market Insights The...
Market Insight Reports · 05/12 06:07
Cathie Wood Loads Up $57M In Palantir As Stock Stages Reversal On Q1 Earnings Beat
Cathie Wood-led Ark Investment Management on Tuesday snapped up 2.8 million shares, worth about $56.7 million, in Palantir Technologies Inc (NYSE: PLTR) after the data analytics company reported strong earnings on Tuesday.
Benzinga · 05/12 05:05
Global Organ-on-a-Chip Market Outlook, Industry Analysis and Prospect 2026
May 11, 2021 (Heraldkeepers) -- Organ-on-a-Chips are AA battery sized microfluidic chips designed accurately to recreate the natural physiology and...
Heraldkeepers · 05/11 05:18
3D Bioprinting Market Latest Report: Top Company Profiles, CAGR, Production And Sales Estimations and Forecast 2026
May 10, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry" “3D Bioprinting Market” report provides a...
The Express Wire · 05/10 10:50
ARK Invest's Cathie Wood Says 3D Printing Will Be 'Extremely' Important For Aerospace
-CNBC interview
CNBC interview · 05/07 19:36
Webull provides a variety of real-time ONVO stock news. You can receive the latest news about Organovo Holdings through multiple platforms. This information may help you make smarter investment decisions.
About ONVO
Organovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products, including 3D human tissues used for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion (ADME), and drug metabolism and pharmacokinetics (DMPK); customized human tissues as living, dynamic models of human biology or disease, for use in drug discovery and development, and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting, nerve grafts for nerve damage repair and functional tissue patches for the repair or replacement of damaged tissues and organs.